Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Parmiani

Showing results (1-10 of 301) with videos related to

Pageof 31
Sort By:
Folia Biologica|January 5, 2001
Immunological therapy of human tumors by gene-modified cellular vaccinesG Parmiani
Immunology Series|January 1, 1994
Immunotherapy of tumors. IntroductionG Parmiani
Melanoma Research|December 1, 1993
T cell-defined melanoma antigens: toward a tumour-specific immunotherapy of the diseaseG Parmiani
International Journal of Cancer|March 15, 1970
Immune-depressive effect of urethan on the homograft response in miceG Parmiani
Immunology Today|November 1, 1993
Tumor immunity as autoimmunity: tumor antigens include normal self proteins which stimulate anergic peripheral T cellsG Parmiani
Transplantation Proceedings|March 1, 1980
Lack of identity between TSTA and alien antigens of methylcholanthrene-induced murine sarcomasG Parmiani
Journal of the National Cancer Institute|September 1, 1971
Skin-graft rejection during lymphomagenesis in urethan-treated miceG Parmiani
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Future perspectives in specific immunotherapy of melanomaG Parmiani
Immunogenetics|February 9, 2011
Genetic control of responsiveness to the tumor-associated transplantation antigen of a chemically induced murine fibrosarcomaG Parmiani
Immunology Today|April 1, 1990
An explanation of the variable clinical response to interleukin 2 and LAK cellsG Parmiani
Pageof 31

Showing results (1-10 of 301) with videos related to

Sort By:
Pageof 31
Folia Biologica|January 5, 2001
Immunological therapy of human tumors by gene-modified cellular vaccinesG Parmiani
Immunology Series|January 1, 1994
Immunotherapy of tumors. IntroductionG Parmiani
Melanoma Research|December 1, 1993
T cell-defined melanoma antigens: toward a tumour-specific immunotherapy of the diseaseG Parmiani
International Journal of Cancer|March 15, 1970
Immune-depressive effect of urethan on the homograft response in miceG Parmiani
Immunology Today|November 1, 1993
Tumor immunity as autoimmunity: tumor antigens include normal self proteins which stimulate anergic peripheral T cellsG Parmiani
Transplantation Proceedings|March 1, 1980
Lack of identity between TSTA and alien antigens of methylcholanthrene-induced murine sarcomasG Parmiani
Journal of the National Cancer Institute|September 1, 1971
Skin-graft rejection during lymphomagenesis in urethan-treated miceG Parmiani
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Future perspectives in specific immunotherapy of melanomaG Parmiani
Immunogenetics|February 9, 2011
Genetic control of responsiveness to the tumor-associated transplantation antigen of a chemically induced murine fibrosarcomaG Parmiani
Immunology Today|April 1, 1990
An explanation of the variable clinical response to interleukin 2 and LAK cellsG Parmiani
Pageof 31